We are live on ! Find out more
RO

Robert Olstein Olstein Capital Management

AUM $458M
1-Year Est. Return 6.27%
 

Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.

This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
+6.27%
3 Year Est. Return
+16.62%
5 Year Est. Return
+3.39%
10 Year Est. Return
+96.48%
AUM
$819M
AUM Growth
+$51.2M
Cap. Flow
-$10.9M
Cap. Flow %
-1.33%
Top 10 Hldgs %
15.85%
Holding
134
New
9
Increased
62
Reduced
38
Closed
16

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.6%
2 Industrials 22.85%
3 Financials 14.66%
4 Technology 14.22%
5 Healthcare 12.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
101
Integra LifeSciences
IART
$1.3B
$3.09M 0.38%
139,449
+4,893
+4% +$99.2K
CULP icon
102
Culp Inc
CULP
$43.5M
$3.04M 0.37%
140,000
+5,000
+4% +$96.4K
CECO icon
103
Ceco Environmental
CECO
$4.19B
$3M 0.37%
193,000
+40,000
+26% +$560K
ACAT
104
DELISTED
Arctic Cat Inc
ACAT
$2.95M 0.36%
83,000
+32,000
+63% +$1.05M
FOXF icon
105
Fox Factory Holding Corp
FOXF
$918M
$2.69M 0.33%
166,000
+128,000
+337% +$1.95M
LCUT icon
106
Lifetime Brands
LCUT
$211M
$2.46M 0.3%
143,000
+41,000
+40% +$654K
HLIT icon
107
Harmonic Inc
HLIT
$1.36B
$2.38M 0.29%
340,000
+10,000
+3% +$66.7K
DAKT icon
108
Daktronics
DAKT
$927M
$2.19M 0.27%
+175,000
New +$2.2M
PBPB
109
DELISTED
Potbelly
PBPB
$2.12M 0.26%
165,000
-46,000
-22% -$582K
WNC icon
110
Wabash National
WNC
$490M
$2.1M 0.26%
+170,000
New +$1.94M
CRL icon
111
Charles River Laboratories
CRL
$14.1B
$2.04M 0.25%
32,000
-89,000
-74% -$5.58M
NUTR
112
DELISTED
Nutraceutical International Co
NUTR
$1.83M 0.22%
85,000
+8,000
+10% +$174K
KAI icon
113
Kadant
KAI
$3.7B
$1.71M 0.21%
40,000
+7,000
+21% +$283K
SCS
114
DELISTED
Steelcase
SCS
$1.71M 0.21%
95,000
-5,000
-5% -$86K
MLR icon
115
Miller Industries
MLR
$649M
$1.58M 0.19%
76,000
+15,000
+25% +$280K
RCKY icon
116
Rocky Brands
RCKY
$351M
$1.22M 0.15%
91,000
+20,000
+28% +$283K
TFX icon
117
Teleflex
TFX
$5.88B
$919K 0.11%
8,000
-55,000
-87% -$6.23M
BLT
118
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
$105K 0.01%
+6,000
New +$96K
CTAS icon
119
Cintas
CTAS
$81.6B
-196,000
Closed -$3.46M
DIS icon
120
Walt Disney
DIS
$186B
-20,000
Closed -$1.78M
ETD icon
121
Ethan Allen Interiors
ETD
$595M
-369,000
Closed -$8.41M
HRL icon
122
Hormel Foods
HRL
$13.1B
-148,000
Closed -$3.8M
KO icon
123
Coca-Cola
KO
$392B
-99,000
Closed -$4.22M
MCD icon
124
McDonald's
MCD
$192B
-33,000
Closed -$3.13M
MMM icon
125
3M
MMM
$92.3B
-14,352
Closed -$1.7M

Similar funds

Robert Olstein's Q4 2014 Portfolio in Review

As of Q4 2014, Robert Olstein held 134 positions worth $819M, up 6.7% from $768M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Robert Olstein's Q4 2014 filing shows 9 new, 62 increased, 38 reduced and 16 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 211,000 shares worth $7.78M. The largest sale was PETSMART INC, an estimated $12.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Financials.

  • Robert Olstein's largest Q4 2014 buy was Twenty-First Century Fox, Inc. Class B: 211,000 shares worth $7.78M.
  • Robert Olstein added most to The Greenbrier Companies in Q4 2014, an estimated $11.5M increase.
  • Robert Olstein's biggest Q4 2014 reduction was Ross Stores, cutting an estimated $6.33M.
  • Robert Olstein fully exited PETSMART INC in Q4 2014, selling an estimated $12.8M.
  • Robert Olstein's ten largest holdings make up 16% of its $819M portfolio in Q4 2014.
  • Robert Olstein opened 9 new positions and closed 16 in Q4 2014.
  • Robert Olstein's portfolio value rose 6.7% quarter-over-quarter to $819M.

Based on Olstein Capital Management's 13F filing for Q4 2014, filed 4 Feb 2015.